Company Information
Company Profile
Avalo Therapeutics, Inc. (AVTX) is a leading clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize highly targeted therapeutics in the areas of Immunology, Immuno-oncology, and Rare Genetic Diseases.
Latest Presentations
November 2022 Investor Presentation
View This Presentation
Cerecor | AEVI Merger Details
Please see the attached to documents for detailed information regarding the Aevi acquisition / merger and or a simple question and answer document
| Name | View Document |
|---|---|
| CERECOR SEC S4 Aevi Acquisition | Download |
| CERECOR Q&A Document | Download |
Contact Information
Investor Relations
Avalo Therapeutics
ir@avalotx.com
ICR Westwicke
Chris Brinzey
Managing Director
T: 339-970-2843
chris.brinzey@westwicke.com
Company Contact
Avalo Therapeutics, Inc.
1500 Liberty Ridge Drive
Wayne, PA 19087